Cargando…

Can a fibrotic liver afford epithelial-mesenchymal transition?

The question whether epithelial-mesenchymal transition (EMT) occurs during liver fibrogenesis is a controversial issue. In vitro studies confirm that hepatocytes or cholangiocytes undergo EMT upon transforming growth factor β (TGF-β) stimulation, whereas in vivo experiments based on genetic fate map...

Descripción completa

Detalles Bibliográficos
Autores principales:	Munker, Stefan, Wu, Yong-Le, Ding, Hui-Guo, Liebe, Roman, Weng, Hong-Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514631/ https://www.ncbi.nlm.nih.gov/pubmed/28765687 http://dx.doi.org/10.3748/wjg.v23.i26.4661

Ejemplares similares

Therapeutic Targeting of Fibrotic Epithelial-Mesenchymal Transition–An Outstanding Challenge
por: Fintha, Attila, et al.
Publicado: (2019)

Can’t Afford It
Publicado: (1862)

The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders
por: Di Gregorio, Jacopo, et al.
Publicado: (2020)

Mental health in diabetes: can’t afford to address the service gaps or can’t afford not to?
por: Sachar, Amrit, et al.
Publicado: (2019)

The Epithelial-to-Mesenchymal Transition in Cancer
por: Roche, Joëlle
Publicado: (2018)

Epithelial–mesenchymal transition in cancer
por: Moustakas, Aristidis, et al.
Publicado: (2017)

Epithelial–Mesenchymal Transition (EMT)
por: Manfioletti, Guidalberto, et al.
Publicado: (2023)

Liver Progenitor Cells in Massive Hepatic Necrosis—How Can a Patient Survive Acute Liver Failure?
por: Lin, Tao, et al.
Publicado: (2022)

Mesenchymal-Epithelial Transition in Oral Cancer
por: Patil, Shankargouda, et al.
Publicado: (2015)

Epithelial–Mesenchymal Transition (EMT) 2021
por: Manfioletti, Guidalberto, et al.
Publicado: (2022)

Sphingolipids modulate the epithelial–mesenchymal transition in cancer
por: Levade, T, et al.
Publicado: (2015)

Revisiting mTOR and Epithelial–Mesenchymal Transition
por: Herrerias, Mariana M., et al.
Publicado: (2020)

How Can We Afford Costly Medicines?
por: Mucklow, John C
Publicado: (2000)

Kinase inhibitors fail to induce mesenchymal-epithelial transition in fibroblasts from fibrotic lung tissue
por: Xu, Xuefeng, et al.
Publicado: (2020)

Lysyl Oxidase at the Crossroads of Mesenchymal Stem Cells and Epithelial-Mesenchymal Transition
por: Thomas, Clémence, et al.
Publicado: (2013)

IL-13 Signaling in Liver Fibrogenesis
por: Liu, Yan, et al.
Publicado: (2012)

Targeting epithelial-mesenchymal transition pathway in hepatocellular carcinoma
por: Song, Jaewhan
Publicado: (2020)

Shoulder arthroscopy and complications: Can we afford to relax?
por: Bhaskar, S Bala, et al.
Publicado: (2015)

Can we afford to treat obstructive sleep apnoea?
por: Raine, Richard
Publicado: (2020)

Special Issue “The Role of Mesenchymal Stem Cells on Inflammatory and Fibrotic Diseases”
por: Di Vincenzo, Mariangela, et al.
Publicado: (2023)

Listen to the WNT; It Talks: WNT7A Drives Epithelial–Mesenchymal Cross-Talk within the Fibrotic Niche in Idiopathic Pulmonary Fibrosis
por: Königshoff, Melanie, et al.
Publicado: (2022)

The Potential Role of Elk-3/Egr-1 Signaling Pathway in the Epithelial-Mesenchymal Transition during Liver Fibrosis
por: Kim, In Hee
Publicado: (2017)

Universal and affordable health care: how can we achieve it?
por: Okamoto, Etsuji
Publicado: (2009)

TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases
por: Pardali, Evangelia, et al.
Publicado: (2017)

Computed tomography vs liver stiffness measurement and magnetic resonance imaging in evaluating esophageal varices in cirrhotic patients: A systematic review and meta-analysis
por: Li, Yue, et al.
Publicado: (2020)

Involvement of epithelial–mesenchymal transition in liver fibrosis
por: Yu, Kangkang, et al.
Publicado: (2018)

Can Price Transparency Contribute to More Affordable Patient Access to Medicines?
por: Vogler, Sabine, et al.
Publicado: (2017)

Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic Diseases
por: Piera-Velazquez, Sonsoles, et al.
Publicado: (2016)

Epithelial–Mesenchymal Transition: A Major Pathogenic Driver in Idiopathic Pulmonary Fibrosis?
por: Salton, Francesco, et al.
Publicado: (2020)

Health of tribal populations in India: How long can we afford to neglect?
por: Narain, Jai Prakash
Publicado: (2019)

Controversies over the Epithelial-to-Mesenchymal Transition in Liver Fibrosis
por: Taura, Kojiro, et al.
Publicado: (2016)

Epithelial–Mesenchymal Transition in Liver Fluke-Induced Cholangiocarcinoma
por: Sawanyawisuth, Kanlayanee, et al.
Publicado: (2021)

1α,25-dihydroxyvitamin D3 Attenuates TGF-β-Induced Pro-Fibrotic Effects in Human Lung Epithelial Cells through Inhibition of Epithelial–Mesenchymal Transition
por: Jiang, Fei, et al.
Publicado: (2017)

Copper Exposure Induces Epithelial-Mesenchymal Transition-Related Fibrotic Change via Autophagy and Increase Risk of Lung Fibrosis in Human
por: Chiou, Hsin-Ying Clair, et al.
Publicado: (2023)

RHBDF1 promotes AP-1-activated endothelial–mesenchymal transition in tumor fibrotic stroma formation
por: Gao, Shan, et al.
Publicado: (2021)

RPE epithelial-mesenchymal transition plays a critical role in the pathogenesis of proliferative vitreoretinopathy
por: Li, Xiaohua, et al.
Publicado: (2020)

Deep Learning–based Classification of Fibrotic Lung Disease: Can Computer Vision See the Future?
por: Choi, Bina, et al.
Publicado: (2022)

Clinical significance of epithelial-mesenchymal transition
por: Steinestel, Konrad, et al.
Publicado: (2014)

Fructose Induces Pulmonary Fibrotic Phenotype Through Promoting Epithelial-Mesenchymal Transition Mediated by ROS-Activated Latent TGF-β1
por: Xu, Xiaoxiao, et al.
Publicado: (2022)

Mesenchymal stem cells in fibrotic diseases—the two sides of the same coin
por: Qin, Lei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_clke4qr83jd9gp2on3tnekl1d1